Trigger-Responsive Nanocarriers for Drug Delivery

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: closed (25 July 2020) | Viewed by 8874

Special Issue Editor


E-Mail Website
Guest Editor
Eventus GmbH, Breitenbachstraße 10, 13509 Berlin, Germany
Interests: skin penetration of topically applied nanomaterials; skin barrier; hair follicle; follicular penetration pathway and mechanism; skin antisepsis; trigger-responsive nanocarriers for increased drug delivery

Special Issue Information

Dear Colleagues,

Nanocarriers are frequently used for drug delivery in many medical applications. In dermatopharmacy, the implementation of nanocarriers for topical drug delivery is also a hot topic of research, as they provide many advantages, such as the transportation of higher drug concentrations, the improved physical and chemical stability of drugs, and the increased solubility of hydrophobic drugs. The great challenge, however, is that these nanocarriers have to overcome a very potent skin barrier. Nanocarriers themselves are hardly able to overcome an intact skin barrier, but recently several approaches have been developed to use the properties of the nanocarriers in order to improve the bioavailability of topically applied drugs. A very promising approach is the development of trigger-responsive nanocarriers, which are able to release their drug-load upon a specific trigger signal at a specific time point and/or desired location. As trigger signals both endogenous (such as pH, temperature) as well as exogenous signals (such as UV or IR radiation) come into consideration, which provide different advantages and disadvantages. Moreover, trigger-responsive nanocarriers might be an innovative tool to implement nanocarriers not only for dermal but also for systemic drug delivery.

Assoc. Prof. Dr. Alexa Patzelt
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Nanocarrier
  • Topical drug delivery
  • Trigger-responsive nanocarrier
  • Endogenous trigger signal
  • Exogenous trigger signal
  • Skin
  • Drug delivery
  • Dermatopharmacy
  • Skin barrier
  • Hair follicle

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 3087 KiB  
Article
Microneedle-Facilitated Intradermal Proretinal Nanoparticle Delivery
by Benchaphorn Limcharoen, Pattrawadee Toprangkobsin, Marius Kröger, Maxim E. Darvin, Titiporn Sansureerungsikul, Teeranut Rutwaree, Supason Wanichwecharungruang, Wijit Banlunara, Jürgen Lademann and Alexa Patzelt
Nanomaterials 2020, 10(2), 368; https://doi.org/10.3390/nano10020368 - 20 Feb 2020
Cited by 21 | Viewed by 4273
Abstract
Topical retinoid treatments stimulate biological activities in the skin. The main physical barrier, which limits the efficacy of transdermal drug delivery, is the stratum corneum. Proretinal nanoparticles (PRN) have already been proven to efficiently deliver retinal into the epidermis. In the present study, [...] Read more.
Topical retinoid treatments stimulate biological activities in the skin. The main physical barrier, which limits the efficacy of transdermal drug delivery, is the stratum corneum. Proretinal nanoparticles (PRN) have already been proven to efficiently deliver retinal into the epidermis. In the present study, two transdermal drug delivery systems, microneedles (MN) and PRN, were combined to directly target the dermis. The microchannels induced by the MN, the PRN localization in the microchannels and the skin closure kinetics were investigated by non-invasive imaging techniques, such as dermoscopy, optical coherence tomography and multiphoton tomography. Additionally, the amount of retinal in the epidermis and dermis after application in three different forms (PRN-Loaded microneedles, PRN suspension or conventional retinal solution) was compared. All imaging techniques confirmed the formation of microchannels in the skin, which were partly still detectable after 24 h. Multiphoton tomography showed the release of PRN from the MN within the microchannels. The recovered retinal concentration in the dermis was significantly higher when applied via PRN-loaded microneedles. We hypothesized that this platform of PRN-loaded microneedles can provide a rapid and efficient administration of retinal in the dermis and could be of benefit in some skin conditions such as atrophic scar or photo-aged skin. Full article
(This article belongs to the Special Issue Trigger-Responsive Nanocarriers for Drug Delivery)
Show Figures

Graphical abstract

18 pages, 5575 KiB  
Article
Biodegradable Micelles for NIR/GSH-Triggered Chemophototherapy of Cancer
by Chuan Zhang, Yuzhuo Wang, Yue Zhao, Hou Liu, Yueqi Zhao, Xiangwei Li and Quan Lin
Nanomaterials 2019, 9(1), 91; https://doi.org/10.3390/nano9010091 - 11 Jan 2019
Cited by 29 | Viewed by 4128
Abstract
The chemotherapy of stimuli-responsive drug delivery systems (SDDSs) is a promising method to enhance cancer treatment effects. However, the low efficiency of chemotherapy drugs and poor degradation partly limit the application of SDDSs. Herein, we report doxorubicin (DOX)-loading mixed micelles for biotin-targeting drug [...] Read more.
The chemotherapy of stimuli-responsive drug delivery systems (SDDSs) is a promising method to enhance cancer treatment effects. However, the low efficiency of chemotherapy drugs and poor degradation partly limit the application of SDDSs. Herein, we report doxorubicin (DOX)-loading mixed micelles for biotin-targeting drug delivery and enhanced photothermal/photodynamic therapy (PTT/PDT). Glutathione (GSH)-responsive mixed micelles were prepared by a dialysis method, proportionally mixing polycaprolactone-disulfide bond-biodegradable photoluminescent polymer (PCL-SS-BPLP) and biotin-polyethylene glycol-cypate (biotin-PEG-cypate). Chemically linking cypate into the mixed micelles greatly improved cypate solubility and PTT/PDT effect. The micelles also exhibited good monodispersity and stability in cell medium (~119.7 nm), low critical micelles concentration, good biodegradation, and photodecomposition. The high concentration of GSH in cancer cells and near-infrared light (NIR)-mediated cypate decomposition were able to achieve DOX centralized release. Meanwhile, the DOX-based chemotherapy combined with cypate-based NIR-triggered hyperthermia and reactive oxygen species could synergistically induce HepG2 cell death and apoptosis. The in vivo experiments confirmed that the micelles generated hyperthermia and achieved a desirable therapeutic effect. Therefore, the designed biodegradable micelles are promising safe nanovehicles for antitumor drug delivery and chemo/PTT/PDT combination therapy. Full article
(This article belongs to the Special Issue Trigger-Responsive Nanocarriers for Drug Delivery)
Show Figures

Graphical abstract

Back to TopTop